PCY: Karissa © Appointment CPC 07/30/2024 Lauren Reason for Appointment 1. 2. Ft transfer Med refills History of Present illness Depression Screening: PHO-9 Little interest or pleasure in doing things Not at all Feeling down, depressed, or hopeless Not at all Trouble falling or staying asleep, or sleeping too much Not at all Feeling tired or having little energy Not at all Poor appetite or overeating Not at all Feeling bad about yourself or that you are a failure, or have let yourself or your family down Not at all Trouble concentrating on things, such as reading the newspaper or watching television Not at all Moving or speaking so slowly that other people could have noticed; or the opposite, being so fidgety or restless that you have been moving around a lot more than usual Not at all Thoughts that you would be better off dead or of hurting yourself in some way Not at all Total Score o History: 59-year-old female with history of hypothyroidism, insomnia, anxiety presenting for medication review and refills. Patient takes 25 mg of trazodone for sleep nightly, hopes to wean off this. Feels her mood overall is stable on current medication regimen. Of note, patient had a hospitalization in April 2024 for bilateral frontoparietal craniotomies for chronic subdural hematomas. This was found on MRI of brain following a head trauma 2 months prior, Patient had been having extreme headaches and dizziness, During this time patient was also placed on Keppra for seizure prophylaxis as well as amlodipine for high blood pressure, she is off both of these now. Patient has residual hand weakness and continues to work with occupational therapy. She is back to regular exercise however still cannot hold weights or hold a tennis racquet due to her weakness. Dr, Alexander Neurological Associates. Gurrent Medications Taking * >. +* Flonase 50 MCG/ACT Suspension 2 sprays in each nostril Nasally Once a day Mucinex 600 MG Tablet Extended Release 12 Hour 1 tablet as needed Orally every 12 hrs Hair Skin Nafls « as directed Orally traZODone HCl so MG Tablet 1 tablet at bedtime as needed Orally Once a day. Notes to Pharmacist: 1/2 tab DULoxetine HCl 60 MG Capsule Release Particles take ene capsule by mouth one time daily Orally a day , Notes to Pharmacist: LAST FILL KEEP UPCOMING APPT Synthroid 112 MOG Tablet 1 tablet Orally Once a day, Notes to Pharmacist: BRAND ONLY! vilACYclovir HC] 500 MG Tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY Oral   Progress Note: Lauren Brunner 07/50/2024 ERE Ee TA “Generated for Printing/Faxing/eTransmitting on: 08/03/2024 02:23 PM EDT 1/30

Hemoglobin 12.5 12.4 12.7 LLOQ 13.0 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: : 11.§-16.0 11.9-16.0 11.5+16.0 11.9+16.0 11.5-16.0 | g/dL) g/dL) g/dL) g/dL} g/dL) Hematocrit 38.4 36.5 38.5 35.5 38.9 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 35.0°47.0 35.0-47.0 35.0-47.0 35.0°47.0 35.0-47.0 %) %) %) %) %) Platelet 233 233 229 219 240 Count (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: 130-400 180-400 180-400 130-400 130-400 K/ul) K/uL) K/uL) K/uL)} K/ul) ; RDW-CV% 12.8 12.7 12.7 12.5 13.8 (Ref (Ref (Ref (Ref (Ref Range: Range: Range: Range: Range: W545 1154.5 1514.5 %) %) %) %) %) Mev 91.6 91.7 93.0 94.4 93.1 (Ref (Ref (Ref (Ref (Ref Range; Range: Range: Range: Range: 80.0-99.0 80,.0-99.0 80.0+99,0 80.0°99.0 80.0-99.0 fL) fL) fL) fL} MCH 29.8 31.2 30,7 31.6 B11 (Ref (Ref (Ref (Ref (Ref ‘ Range: Range: Range: Range: Range: 26.0-34.0 26.0-34.0 26.0-34.0 26.0-34.0 26,0-34.0 pg) Pg) Pg) pg) pg) MCHC 32.6 34.0 33.0 33.5 33.4 (Ref (Ref (Ref (Ref (Ref 1 Range: Range: Range: Range: Range: 31,0°35.0 31.0°35.0 31,0°35.0   g/dL} g/dl) g/dl) g/dl) g/dL) Lymphocyte 30.2 31.5 37.5 38.4 29.0 3% (Ref (Ref (Ref (Ref . (Ref Range: Range: Range: Range: Range: VW74-5L7 1749517 17.4°51.7 %) %) %) %) 7%) Mono% 6.8 8.3 6.6 7.0 5.3 (Ref (Ref (Ref (Ref (Ref Range: 4.5-Range: 4.5-Range: 4.5-Range: 4.5- 12.5%) 125%) 125%) 125%) 12.5 %) EOS% 2.6 3.3 3.1 2.5 2.0 (Ref (Ref (Ref (Ref (Ref i Range; 6.5-Range: 0.9-Range: 0.9-Range: 0.5-Range: 0.5- 5.8%) 5.8%) §.8%) 5.8%) Punnnnce Nintos BIN

Page 8 of 10 1740, (136-145 mmol/L) 138 Potassium (3.5-5.1 mmol/L) 4.5. Chloride (98 - 107 mmol/L) 102 Carbon Dioxide (21 - 32 mmol/L) 27 Anion Gap (5 - 15) 9 BUN (7 - 18 mg/dL) 11 Creatinine (0.55 - 1.02 mg/dL) 0.64 Estim Creat Clear Calc 95.5 Est GFR (CKD-EPI) mL/min) 101.741 Glucose (74 - 106 mg/dL) 93 Calcium (8.5 - 10.1 mg/dL) 9.2 Hematology WEC (3.70 - 11.50 10*3/uL) 7.44 RBC (3.70 - 5.17 10*6/uL) 4.26 ~ Het (30.4 - 44.6 %) 38.4 MCV (75.6 - 97.8 fL) 90.1 MCH (24.3 - 33.2 pg) 30.0 MCHC (31.9 - 35.1 g/dL) 33.3 RDW Coeff of Var (12.1 - 16.8 %) 12.5 Pit Count (156 - 380 10*3/uL) 315 MPV (7.0 - 10.7 fL) 10.0 Immature Gran % (Auto) (0.0 - 0.6 %) 0.3 Neut % (Auto) (%) 61.7 Lymph % (Auto) (%) 29.6 Mono % (Auto) (%) 5.4 Eos % (Auto) (%) 2.2 Baso % (Auto) (%) 0.8 Nucleat RBC Rel Count (NONE SEEN /100 WBC) 0.0 # (Auto) (1.70- 8.00 10*3/ul) 4.60 Lymph # (Auto) (1.10 - 3.80 10*3/uL) 2.20 Mono # (Auto) (0.30 - 0.90 10*3/uL) 0.40 Eos # (Auto) (0.00 - 0.50 10*3/uL) 0.16 Baso # (Auto) (0.00 - 0.10 10*3/uL) 0.06 Immature Gran # (Auto) (10*3/uL) 0.02 Absolute Nucleated RBC (10*3/uL) 0.00

Order Date: 04/03/24 —Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status LAB CBC W/O DIFF 20240404-0245 04/04/24 0400 R E CMP Other Provider : Sig Lvl Provider : Order’s Audit Trail of Events 1 04/03/24 1553 AP.GILRI Order ENTER in POM 2 04/03/24 1553 AP.GILRI Ordering Doctor: Gilliam,Richard R NP 3 3/           04/03/24 1623 3BAZ0038 order acknowledged   Ordered By GILRI1                 5 6 04/04/24 0001 interface cc’d doctors edited in LAB 7 04/04/24 0001 interface order's status changed from TRANS to LOGGED by LAB 8 04/04/24 0611 interface order’s status changed from LOGGED to IN PRO by LAB 9 04/04/24 0616 interface order’s status changed from IN PRO to COMP by LAB Order Date: 04/03/24 ——Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status Ordered By LAB BASIC METABOLIC PROF W/REFLEX 20240404-0246 04/04/24 0400 R E CMP GILRI1 Other Provider : Sig Lvl Provider : Order’s Audit Trail of Events 1 04/03/24 1553 AP.GILRI Order ENTER in POM 2 04/03/24 1553 AP.GILRI Ordering Doctor: Gilliam,Richard R NP 3 04/03/24 1553 AP.GILRI Order Source: EPOM order acknowledge 6 04/04/24 0001 interface cc'd doctors edited in LAB 7 04/04/24 0001 interface order’s status changed from TRANS to LOGGED by LAB 8 04/04/24 0611 interface order’s status changed from LOGGED to IN PRO by LAB 9 04/04/24 0634 interface order's status changed from IN PRO to COMP by LAB Order Date: 04/03/24 —Service— Category Procedure Name Order Number Date Time Pri Qty Ord Source Status Ordered By MED.COCHR MULTIDOSE MEDICATIONS 20240404-0656 04/04/24 0600 R 1Z OSBER Other Provider : Sig Lv] Provider : DEDMANENT DECTONDN

Order Date: 04/04/24 Category Procedure Name NUR.PHYS Discharge Criteria Other Provider : Press (ENTER) for Order Det Comme t: Order’s Audit Trail of Event 04/04/24 04/04/24 04/04/24 04/04/24 04/04/24 04/04/24 0925 DR.WILDA4 0925 DR.WILDA4 0925 DR.WILDA4 0925 DR 0925 interface 1313 3NNI9254   10 04/06/24 2055 PWSNS10 11 04/06/24 2055 PWSNS10 12 04/06/24 2055 PWSNS10 13 04/06/24 2055 PWSNS10 14. 04/06/24 2058 PWSNS10 —Service— Order Number Date Time Pri Qty Ord Source Status 20240404-0494 04/04/24 0925 IPR der : Ordered By WILDA4 Sig Lvl Provi ails below D/C PT FROM PACU WHEN CRITERIA MET Order ENTER in PO Order from set: PACU Adult Ordering Doctor: Williams G.A. Order Source: EPO MD     status cha order acknowledged nged from TRANS to ACTIVE by NUR     Order RECEIVE in NUR Ordering Doctor: Kohout,Jaromir MD Order Source: EPO Order continued upon patient transfer. order acknowledged     Order Date: 04/04/24 Category Procedure Name NUR.PHYS Notify MD Other Provider : Press (ENTER) for Order Det Comment : Order’s Audit Trail of Event 04/04/24 04/04/24 04/0 0925 DR.WILDA4 0925 DR.WILDA4 0925 DR.WILDA4                       14/ 04/04/24 04/06/24 1313 3NNI9254 1652 DR KOHJAL /06/24     10 2055 11 /06/24 2055 PWSNS10 12 /06/24 2055 PWSNS10 13 /06/24 2055 PWSNS10 —Service— Ordered By Order Number Date Time Pri Qty Ord Source Status E WILDA4 20240404-0495 04/04/24 0925 IPR Sig Lv] Provider : ails below Notify provider of HH results if ordered s Order ENTER in POM Order from set: PACU Adult Ordering Doctor: G.A. der. So MD                       order acknowledged Order marked to be continued upon    Order RECEIVE in NUR Ordering Doctor: MD Order Source: EPOM Order continued upon patient transfer. PERMANENT MEDICAL RECORD COPY

Diagnosis/Problem/OQutcome/Care Description StS Frequency Documented Diagnosis /Problem/Outcome/Care Description Sts Frequency   Occurred Recorded ype i b i Date Comment Unies Activity Occurred Recorded Documented Eype 2 i i Time by Date Time by Comment. Units Activity Date: 04/03/24 Time: 2000 Activity Date: 04/03/24 Time: 2015 220430 Teach/Educate + A cp 04/03/24 2000 CW 04/03/24 2327 - - PATIENT/FAMILY TEACHING - - Primary learner: Patient Primary learners preferred spoken language: ENG ENGLISH Primary learners preferred written language: ENG ENGLISH Physiological topics: Blood pressure Functional topics: Activity care Psychological topics: Neurological system care Coping support Health behavior topics: Medication actions Person(s) educated: Patient Readiness to learn: Cooperative Method of education: Verbal discussion Responsiveness to learning: Verbalized understanding Physical regulation topics: Blood pressure Activity topics: Activity care Cognitive/Neuro topics: Neurologic system care Coping topics: Coping support Medication topics: Medication actions 220700 Plan of Care + A cP - Document 04/03/24 2000 CW: 04/03/24 2327 CW - - NEUROLOGICAL ALTERATION - - Neurological alteration problem expected to: Improve/Resolve Target date: 04/30/24 Neurological alteration problem is: Stabilizing/Maintaining - - INFECTION ALTERATION - - nfection alteration problem expected to: Improve/Resolve Target date: 04/30/24 nfection alteration problem is: Stabilizing/Maintaining - - ACTIVITY ALTERATION - - Activity alteration problem expected to: Improve/Resolve Target date: 04/06/24 Activity alteration problem is: Stabilizing/Maintaining - - ANXTETY ALTERATION - - Anxiety alteration problem expected to: Improve/Resolve Target date: 04/30/24 Anxiety alteration problem is: Stabilizing/Maintaining - - INJURY RISK PROBLEM - - njury risk problem expected to: Stabilize/Maintain larget date: 04/30/24 njury risk problem is: Stabilizing/Maintaining - - MAIN SCREEN SELECTIONS - - problem/alteration in: Infection Neurological Functional problem/alteration in: Activity Psychological problem/alteration in: Anxiety Health behavior problem/risk: Injury risk       220411 Clinical Monitor Interface + A MO - Document 04/03/24 2015 OW 04/04/24 0311 Cw Pulse: 93 Respiratory rate: 39 Blood pressure: 126/61 SPO2 %: 100 See next page See next page Mean arterial pressure: 86 See_next_page Activity Date: 04/03/24 Time: 2030 220411 Clinical Monitor Interface + A MO Document 04/03/24 2030 Gn 04/04/24 0311 Pulse: 84 Respiratory rate: 21 Bleod pressure: 128/63 SPG2 %: 100 See next page See next page Mean arterial pressure: 89 See_next page Activity Date: 04/03/24 Time: 2045 220411 Clinical Monitor Interface + A MO - Document 04/03/24 2045. CW: 04/04/24: 0311: (CW Pulse: 83 Respiratory rate: 34 Blood pressure: 125/63 SPO2 %: 100 See next page See next page Mean arterial pressure: 87 See_next_page   220281 Document Frequent Neuro Checks + A PS 04/03/24 Cw 04/08/24 2156 - - FREQUENT NEURO CHECKS - - Level of consciousness: Awake/Alert - - GLASGOW COMA SCALE - - Document Glasgow coma scale: Yes Eye opening: 4 Yerbal resporse: 5 Motor response: 6

Diagnosis/Problem/Outcome/Care [tem Description Sts Frequency Diagnosis /Problem/Outcome/Care Them Description Sts Frequency Occurred Recorded Documented   Activity Occurred Recorded Documented I ate Time by Date Time by Comment Units Activity Date: 04/03/24 Tite: 2100 (continued 220281 Frequent Neuro Checks + (continued) Glasgow coma score: 15 Mild - - Copyright - - Adults: Sir Graham Teasdale Pediatrics: Copyright owned by Matthew Kirschen, MD PhD Received permissions on 4/22/20 LUE moter strength: Strong UE motor strength: Strong LLE motor strength: Strong LE motor strength: Strong LUE movement: Obeys UE movement: Obeys LLE movement: Obeys LE movement: Obeys Left pupil reaction to light: Brisk ight pupil reaction to light: Brisk Left pupil size: 3mm ight pupil size: 3mm Eye movement: Full range DOUBLE VISION Facial symmetry: Intact Vocalization: Appropriate 220411 Clinical Monitor Interface + A - 04/03/24 2100. CW 04/04/24 0311. CW Pulse: 80 espiratory rate: 26 Blood pressure: 130/66 SPO2 %: 100 See next page See next page Mean arterial pressure: 91 See_next page   Activity Date: 04/03/24 Time: 2107 220411 Clinical Monitor Interface + A ~ 04/03/24 2107 CW 04/04/24 O3T1 CW Pulse: 82 Respiratory rate: 32 See next page See next page See _next page Activity Date: 04/03/24: Time: 2122 220411 Clinical Monitor Interface + A - Document 04/03/24 2122 Cw 04/04/24 O39) CW Pulse: 75 Respiratory rate: 21 MO MO Activity Activity Date: 04/03/24 Date Time Date time by Units Time: (continued 220411 Clinical Monitor Interface + (continued) Blood pressure SPO2 %: 99 See next page See next page : 182/66 Mean arterial pressure: 94 See_next page Activity Date: 04/03/24 Time: 2130 220411 Clinical Monitor Interface + A MO = Bocument Pulse: 77 Respiratory ra Blood pressure: SPO2 %: 97 See next page See next page Mean arterial See_next_page 04/03/24 2130: CW 04/04/24 CW te: 19 127/65 pressure: 90   220411 - Document Pulse: 72 Respiratory ra Blood pressure: %: 97 See next page See next page Mean arterial Activity Date 220411 = Pocument Pulse: 74 Respiratory ra   Blood pressure: SPO2 %: 98 See next page See next page Mean arterial See next page   Clinical Monitor Interface + A MO 04/03/24 2145 CW CW te: 23 126/66 pressure: 91 2 04/03/24 2200 Clinical Monitor Interface + A MO 04/03/24 2200. CW 04/04/24 0311 CW   te: 19 126/69 pressure: 93